O'Shaughnessy Asset Management, LLC Eli Lilly & CO Transaction History

O'Shaughnessy Asset Management, LLC

$9.51 Billion
Q2 2024

A detailed history of O'Shaughnessy Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 106,059 shares of LLY stock, worth $93.1 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

106,059

Previous 102,112 3.87%

Holding current value

$93.1 Million

Previous $79.4 Million 20.88%

% of portfolio

1.01%

Previous 0.89%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $2.86 Million - $3.59 Million	3,947 Added 3.87%	106,059 $96 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $3.92 Million - $5.24 Million	6,611 Added 6.92%	102,112 $79.4 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $6.06 Million - $7.15 Million	-11,541 Reduced 10.78%	95,501 $55.7 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $4.11 Million - $5.67 Million	9,459 Added 9.69%	107,042 $57.5 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $3.16 Million - $4.22 Million	9,002 Added 10.16%	97,583 $45.8 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $1.9 Million - $2.23 Million	-6,103 Reduced 6.45%	88,581 $30.4 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $3.55 Million - $4.14 Million	11,051 Added 13.21%	94,684 $34.6 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $3.77 Million - $4.3 Million	12,731 Added 17.96%	83,633 $27 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $4.31 Million - $5.06 Million	15,462 Added 27.89%	70,902 $23 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $4.53 Million - $5.63 Million	19,298 Added 53.39%	55,440 $15.9 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $1.06 Million - $1.32 Million	4,732 Added 15.07%	36,142 $9.98 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $1.74 Million - $2.14 Million	7,837 Added 33.25%	31,410 $7.26 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $555,371 - $718,369	-3,076 Reduced 11.54%	23,573 $5.41 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $31.7 Million - $41 Million	-192,952 Reduced 87.86%	26,649 $4.98 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $43.5 Million - $57.6 Million	-333,397 Reduced 60.29%	219,601 $37.1 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $20.4 Million - $23.6 Million	-139,461 Reduced 20.14%	552,998 $81.9 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $12.6 Million - $15.2 Million	-92,727 Reduced 11.81%	692,459 $114 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $15.9 Million - $19.7 Million	133,656 Added 20.51%	785,186 $109 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $30.3 Million - $37.6 Million	283,552 Added 77.06%	651,530 $85.6 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $30.3 Million - $32.9 Million	283,657 Added 336.4%	367,978 $41.2 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $7.78 Million - $9.08 Million	70,183 Added 496.41%	84,321 $9.33 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $163,403 - $192,337	-1,468 Reduced 9.41%	14,138 $0
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $668,758 - $749,211	6,315 Added 67.97%	15,606 $1.81 Million
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $797,725 - $997,017	9,291 New	9,291 $997,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Account

O'Shaughnessy Asset Management, LLC Eli Lilly & CO Transaction History